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Abstract: New methods to screen for and identify early-stage dementia disorders are highly sought
after. The purpose of this pilot study is to develop a study protocol for a dual-task test aimed at
aiding the early detection of dementia disorders. We used the Timed Up-and-Go (TUG) test, which is
a mobility task involving starting in a sitting position, standing up, walking three meters to cross a
line on the floor, turning around, walking back and sitting down again. We combined TUG with the
verbal task of naming different animals. Pilot study participants were 43 individuals with and without
established dementia diagnoses who attended a clinic for memory assessment. Video-recorded test
performances were systematically analysed. Deviant test performances concerning the interplay
between test administration and participants’ responses to the assessment instructions were revealed
and led to refinements being made to the final study protocol. Exploration of the dual-task test
outcome measures in a sub-sample of 22 persons, ten with and twelve without dementia, indicated
that step-length and number of named animals after the turning point of the dual-task test might
constitute appropriate measures for examining this kind of sample. We concluded that the refined
study protocol is feasible for testing individuals undergoing initial memory assessments and healthy
controls. Follow-up studies with larger samples are being carried out and will bring new knowledge
to this area of research. It may also provide an opportunity for further studies exploring possibilities
for broad clinical implementation.
Keywords: screening; memory assessment; feasibility; study protocol; dementia diagnosis; cognitive impair
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1. Introduction
Dementia disorder is a complex syndrome and chronic illness, characterised by a global and
irreversible cognitive decline that is severe enough to undermine the performance of activities of daily
living (ADL). The causes are physical changes in the brain, most commonly due to Alzheimer’s disease
(AD) [1]. Dementia impairs multiple higher functions, including memory, orientation, comprehension,
learning, calculation, judgment, and verbal functioning. Other, less severe cognitive impairment
diagnoses such as mild cognitive impairment (MCI) and subjective cognitive impairment (SCI) may
represent transitional stages between normal ageing and dementia. The diagnosis of MCI is defined
as a cognitive impairment that is greater than what is to be expected in relation to the person’s age
and education but does not affect ADL [2], whereas SCI has been regarded as a possible forerunner of
MCI [3]. Moreover, a pre-dementia “motor cognitive risk syndrome” characterised by slow gait and
cognitive complaints has been introduced, and the need for accurate concepts for the identification of
modifiable risk factors among people with this syndrome has been stressed [4,5].
It has been estimated that approximately 75% of people with dementia disorders in the world have
not yet been diagnosed, and the majority of people with dementia disorders are diagnosed in the later
stages of the illness [6]. This implies a significant treatment gap. Screening for the early identification
of cognitive impairment and dementia disorders is, therefore, crucial for the implementation of
measures that will ameliorate symptoms and increase the quality of life for afflicted patients and their
relatives [6,7]. Currently, there is no simple way to diagnose dementia early on. The Mini Mental State
Examination (MMSE) [8] is the best-established screening test for cognitive function and is widely
used in clinical settings and research. A recent study has shown that a three-step screening program,
with MMSE as the starting point, could enhance the diagnosis of dementia disorders and, also, increase
healthcare utilization related to diagnosed dementia disorders among community-dwelling people
aged 60 years and above [9]. However, the MMSE does not provide measurements of cognitive
capabilities that are completely reliable. The floor and ceiling effects for different groups, as well as the
lack of evaluation of executive functions, have been noted as weaknesses [10]. In a Cochrane review,
it was concluded that MMSE is not suitable as a stand-alone single-administration test classification for
the identification of individuals with MCI that could progress to a dementia disorder [11]. As such,
MMSE cannot be used alone as a diagnostic instrument and is unsuited for early diagnosis. On the
other hand, gait disturbances have been associated with cognitive impairment in an increasing number
of studies [12–14]. It has been concluded that there is no causal link between cognitive and motor
dysfunction, but findings reflect the fact that the control of such functions stems from overlapping
neuronal networks in the central nervous system [13]. Studies that have demonstrated a connection
between the control of gait and cognitive functions have supported the proposal to incorporate gait
testing into memory assessment, since gait tests may have the potential to support early identification
of cognitive impairment [15].
Studies have also shown that reduced cognition is associated with poorer performance of the Timed
Up-and-Go test (TUG) [16,17]. TUG is a well-established, uncomplicated, and quickly administrated
test of one movement sequence: starting from a sitting position in an armchair, standing up and walking
three meters, turning around, walking back to the chair, and sitting down again [18]. The original
outcome is the time it takes to complete the test. TUG is well tested for the assessment of gait and
mobility and has shown good reliability for people with AD [19]. It has been indicated that both
reduced gait speed and TUG performance could predict future cognitive decline [16].
Individuals with dementia disorders also demonstrate marked changes in their gait when
completing tasks that require dual-task attention: for example, gait combined with a simultaneous
verbal task, compared with cognitively healthy individuals from the same age group [20–22]. Therefore,
gait tests combined with a simultaneous verbal task have been suggested to have the potential of
serving as a support in the early identification of cognitive impairment and dementia disorders [13,23].
The conclusions drawn are that adequate gait testing may be helpful for the detection of early stages of
cognitive impairment, as well as an increased risk of falling associated with cognitive decline. Research
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is therefore increasingly directed towards the new paradigm in which mobility and cognition are
viewed as interrelated and that there is a need for an integrated assessment approach that includes
both these domains [24]. Such an approach can be achieved through dual-task testing, which has been
shown to be more sensitive to cognitive decline than single-task gait performance measures [25,26].
Gait parameters derived from dual-task tests have additionally been suggested as markers for detecting
dementia [20,27,28]. One suggested explanation for these results is that dual-task testing can serve
as a brain stress test with the potential of revealing degrees of cognitive impairment at a subclinical
stage [29]. The advantages of such tests are that they can be simply conducted in a clinical setting,
the performance/results of the test are barely affected by education level, and the gait test is ecologically
valid since it relates to ADL [5,13]. Thus, TUG testing with dual-task performance could be regarded
as a potentially valuable clinical tool for screening and enabling treatment planning for patients with
cognitive impairment [30].
Previous TUG dual-task research, regarding differentiating patients with dementia disorders,
cognitive impairment diagnoses, and healthy controls, has focused on time scores [31,32]. The TUG as a
component in dual-task testing has also been used to investigate gait parameters, where stride frequency
appeared to correlate with the level of cognitive function [33]. Further research, however, is required
to explore results from TUG dual-task performance among people with different levels of cognitive
functioning as well as its capacity to predict future cognitive decline and future dementia diagnosis.
Research Objectives
With the purpose of providing a screening test that can aid the early detection of dementia
disorders, we have developed a TUG dual-task test (TUGdt) procedure. This test involves TUG being
performed simultaneously with the verbal task of naming different animals, which we have previously
used in a study with individuals with mild AD [32]. For this new purpose, we are planning to evaluate
the prognostic power of the TUGdt test’s outcomes through an initiated large-scale longitudinal cohort
trial named the Uppsala Dalarna Dementia and Gait study (UDDGait).
In an attempt to respond to the currently highlighted need for more publications in this field and
the sharing of feasibility work concerning non-randomised studies [34], we are hereby reporting on
the processes of the pilot study for feasibility evaluation, preparatory work and the development of
the UDDGait protocol.
The overall aim of this pilot study is to develop and refine a feasible UDDGait protocol.
Specific objectives are to:
1. Identify adaptations to improve the content and structure of the study protocol in cooperative
consensus processes with expert clinicians and researchers in the area of memory assessment.
2. Identify possibilities for refinement of the assessment procedures based on investigations of
uncertainties concerning the interplay between TUGdt administration and participants’ responses
to the assessment instructions by the use of video-recorded test performances.
3. Explore potentially useful TUGdt outcome measures based on TUGdt assessments of a small
sample of individuals attending a specialist clinic for memory assessment.
2. Material and Methods
2.1. Study Design
A mixed methods approach was adopted in this observational pilot study. The current article
follows the main features of Consolidated Standards of Reporting Trials (CONSORT) extensions to
pilot trials (https://www.equator-network.org/reporting-guidelines/consort-2010-statement-extension-
to-randomised-pilot-and-feasibility-trials/), as suggested for pilot and feasibility studies in preparation
for non-randomised cohort studies [34].
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2.2. Ethical Approval and Patients’ Consent to Participate
An effort was put on adapting all information to the participants to make it clear, understandable
and objective, and to provide a good base for informed consent. If the participant wished, we also
informed their relatives. The agreement for participation includes a possibility to choose whether
or not retouched (to preserve personal integrity) video-recordings of the data collection are allowed
to be shown in relation to scientific presentations. This was not a requirement for participation.
Only video-recordings from individuals who have provided consent for us to use them are shown
as part of the results presentation. The Regional Ethical Review Board in Uppsala has approved the
UDDGait, including the current pilot study, Dnr. 2014/068.
2.3. Pilot Setting and Participating Patients
For the pilot study, participants were recruited among patients who were scheduled for a memory
assessment visit or a re-visit at the specialist clinic of Uppsala University Hospital, Uppsala, Sweden,
during a period of four weeks. The exclusion criteria were inability to walk three meters back and forth
or to rise up from a sitting position, indoor use of a walker, need of an interpreter to follow instructions
given in Swedish, current or recent (within the last two weeks) hospitalization, and disapproval from
either a treating physician or a close relative.
During the study period, 84 memory assessment appointments were completed. Thirty of these
patients declined study participation. The most common reasons for declining were “want to focus on
my medical appointment”, “cannot manage it”, and “do not want to”. Another five patients declined
due to disapproval from their physician or a relative. These disapprovals were motivated by the risk
of study participation disturbing the medical appointment. Six patients were excluded in accordance
with the exclusion criteria: need of an interpreter (n = 5), and walking impairment (n = 1) (Figure 1).
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Figure 1. Flow chart for the inclusion in the pilot study.
The remaining 43 patients were included. Their median age was 74 years (range: 58–87 years),
26 were men, and 25 had an established dementia disorder diagnosis (DD) while 18 had no established
dementia diagnosis (NoDD). Among the latter, nine had MCI, and nine needed further assessment
before a diagnosis could be established (Table 1). We used convenience sampling, based on non-deviant
TUGdt performance according to the qualitative video analyses (see below) for a sub-sample of
participants for the exploration of TUGdt outcome step length (SL) extracted from the video data
(Table 1).
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Table 1. Overview of the total study sample (n = 43) and the sub-sample (n = 22).
Dementia Diagnosis No Dementia Diagnosis All
Total sample (n) 25 18 43
Age (years), Md (range) 77 (59–87) 72 (58–83) 74 (58–87)
Female n, (%) 10 (40) 7(38) 17 (37)
MMSE (scores), Md (range) 22 (20–24) 26 (21–29) 22 (20–27)
Sub-sample (n) 10 12 22
Age (years), Md (range) 78 (62–87) 70 (58–76) 71 (58–87)
Female n, (%) 4 (40) 6 (50) 10 (45.5)
MMSE (scores), Md (range) 20.0 (15–27) 27.5 (19–30) 26.0 (15–30)
MMSE = Mini Mental State Examination, Md = Median.
2.4. Pilot Test Procedures, Data Collection and Analyses
Collection of data for our three specific pilot objectives: (i) identification of adaptations to improve
the study protocol, (ii) identification of possibilities for refinement of the assessment procedures,
and (iii) exploration of potentially useful TUGdt outcome measures, were carried out in somewhat
overlapping processes, described below.
Two of the authors (Y.C. and A.C.Å.) are both researchers and physiotherapists (Pt) specialised
in geriatrics, with experience from clinical work and research on dual-task testing in memory
assessment [21,32]. They created the basis for the pilot study protocol. Refinement of this protocol
involved the assessor (AS), who is a Pt and MSc-student with experience in geriatric care. She carried
out all the data collection in terms of clinical tests. A checklist to standardise the TUGdt procedures
was developed and used and supervised training sessions with expert feedback (by the responsible
Pts) were accordingly carried out.
Face-to-face consensus meetings were held with a team of clinicians and researchers (including a
neuropsychologist, nurses, occupational therapists, social workers and specialist physicians) working
at the study site. The goals were to spread information about the study, facilitate cooperation for the
data collection, and receive input regarding methodology. For evaluation from a patient’s point of view,
one older person without cognitive impairments was recruited at a nearby out-patient ward, tested,
and interviewed about the structure, test order, instructions, time, and any difficulties experienced
during the testing. This latter process resulted in only minor refinements being made.
Collection and processing of patients’ data were blinded in relation to diagnoses. Demographic
data was collected through oral reports from the participants and, if he/she so wished, also from their
relatives. All testing followed the same procedure and was carried out according to standardised
written protocols in the memory clinic setting, as mentioned above. Participants’ heights (with shoes
on) were measured and established clinical tests of cognition and motor functions were performed in
accordance with standard protocols and were mainly used for descriptive purposes, i.e., hand grip
strength of the dominant hand using a dynamometer (Patterson Medical, Sutton-in-Ashfield, UK),
mobility by the General Motor Function Assessment Scale [35,36], cognitive functions using the Mini
Mental State Examination (MMSE) [8], and the Clock Test [37]. The diagnoses were collected from the
medical records in connection to the data entry.
2.4.1. Timed Up-and-Go and Timed Up-and-Go dual-task tests
A standardised set up was used for the TUG and TUGdt tests, including video documentation.
The TUGdt consisted of TUG combined with the verbal attention-demanding task of naming different
animals, which challenges semantic memory and executive function [38,39]. The task of naming
animals is based on a well-established verbal fluency test [40], which is commonly used for assessing
semantic memory and has been used as a component in various dual-task tests [24,41].
The starting position of the participant was sitting in an armchair placed three meters in front of a
marked line on the floor. They were allowed to use their hands to help them stand up. Instructions
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were given verbally and testing was initiated by a trial TUG test alongside the assessor before the
actual testing was started. Then the TUG test was performed followed by the TUGdt test. Instructions
for both tests were, as stipulated on the checklist: Walk at a self-selected, comfortable speed, pass the
marked line, turn around and walk back to the chair, sit down again. The TUGdt test had the additional
instruction: Name different animals while walking, if you cannot think of any animals, continue
walking and finish the mobility task. In other words, participants were asked to prioritize walking
over the verbal task during the TUGdt test.
The TUG and TUGdt tests were timed by the assessor with a stopwatch to the nearest 0.01 s. from
the participant rising up (his/her back leaving the chair’s backrest) to sitting down (his/her posterior
touching the chair’s seat). To capture the TUG and TUGdt test outcomes concerning the mobility
and verbal performances as well as SL, these tests were recorded using two cameras (Sony NEX-5T,
Sony Corporation, Tokyo, Japan). One was placed two metres in front of the line where the subjects
turned, and the other was four metres to the side of the line.
2.4.2. Analyses
Systematic qualitative analyses of all the TUGdt video recordings (n = 43) were carried out by Y.C.
and any uncertainties were checked and discussed with A.C.Å. This resulted in a systematic presentation
of identified deviant mobility and verbal performances related to the TUG test’s sub-sequences and in
general: (i) Initiation including rising up from the chair, (ii) Walking 3 m to the line, (iii) Line crossing
and turning, (iv) Walking back 3 m to the chair, (v) Sitting down on the chair (Table 2A,B). Viewing and
listening to the video recordings allowed the total number of animals recited to be counted. This also
enabled repeated viewings and hence validation of this data collection. Unusual/indistinct words
could be investigated to determine if they denoted an animal or not. Since the qualitative analysis
of the videos indicated that differences could be found between verbal and gait performances before
and after the TUGdt turning, it inspired us to further explore this as being potentially useful TUGdt
outcome measures.
The following outcome measures from the sub-sample (n = 22) were explored: time scores for
TUG and TUGdt tests, TUGdt cost, i.e., relative time difference calculated as 100*(TUGdt time−TUG
time)/TUG time [42], as well as number of animals recited in total as well as before and after the turning
point, number of animals per ten seconds of TUGdt as well as SL before and after the turning point in
both TUG and TUGdt.
To quantify SL, the video-data processing involved the digitalisation of the positions of the right
and left heel and toe, respectively, derived from video data from the camera with a sagittal view.
This analysis involved identifying images with heel ground contact, and in the image identify (digitise)
the lower-posterior part of both heels in order to calculate the step length. The digitalisation and
subsequent reconstruction of the xy coordinates of the heel and toe positions were performed using
the software SkillSpector Version 1.3.2 (Video4Coach, Odense, Denmark). The reconstruction was
based on the direct linear transformation using known positions of markings on the floor, i.e., a square
of two metres (parallel to the gait direction) × 1.45 m (across the gait direction) in the middle of the
three-metre walkway of the TUG set up. This method for extraction of SL from the video recordings
required extensive manual work and took 40–60 min per TUGdt test trial.
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Table 2. Overview of results from qualitative analysis of video recorded Timed Up-and-Go dual task test performances and the verification protocol developed
through interpretation of these results.
Mobility- A) Observations of Deviant Performance B) Verification Protocol (Based on A)
Sequence Mobility Verbal Normal Performance Deviant Performance
Initiation and rising
up from the chair
Starts during the instructions
Rises and stands still/
and asks: Shall I start at once?
Asks: Shall I start with the
animals?/Shall I say it
out loud?
Starts after finished instructions
Rises and starts walking
Asks about the verbal and/or
mobility performance at the start
Walking 3 m to
the line
Stops walking
Stops walking before the line
Stops after the turn
Asks: Shall I turn?
Tells a story about animals
Asks: Shall I talk about the
animals now?
Walks without any stops Stands still >1 s.
Line crossing
and turning
Turns before the line/with one foot on/two
feet on the line
Wide turn
Walks (2 m) up to the camera before turning
Asks: Shall I turn here?
Passes the line.
Turns with at least one foot over the line
No foot over the line
More than two stances
(i.e., more than one step) before the
turn is initiated
Stands still >1 s.
Walking back 3 m
to chair Stops walking
Asks: Shall I say the same
thing now?
Walks without any stops to the chair and
turns (to sit down) Stands still >1 s.
Sitting down
on chair
Walks to/past the chair and
stands still
Asks: Shall I sit down? /
Is this enough?
Sits down spontaneously Does not spontaneously sit downWalks past the chair





Verbal hesitation or correction of words
Small talk combined with naming animals
Says nouns that are not animals
Says nothing
Discontinues the test
Asks questions about the mobility
or verbal tasks during the test
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2.4.3. Statistical Analyses
To assess the reliability of the data processing for the digitalised SL, a testing procedure was
carried out by analysing the same step (taken from the middle of the TUGdt performance) three times
for each participant. This procedure was repeated three times for one chosen step in each video so
that the reliability of this procedure could be evaluated. From these measurements, the intra-assay
coefficient of variation (CV) was calculated.
Descriptive statistics presented as frequencies and median (minimum–maximum) values were
calculated. Due to the small sample size, we used non-parametric methods for the analysis of the
median with minimum and maximum values for the description. Comparisons between SL and the
number of named animals before vs. after turning were performed for the whole study group using the
Sign Test. Comparisons between groups were made with Willett’s residual method [43] and adjusted
for age, gender, and height. Correlations were estimated as Spearman partial correlation coefficients
and adjusted for age, gender, and height.
3. Results
3.1. Identification of Possible Refinements of the Study Protocol and Assessment Procedures
Feasibility of the assessment procedures was found to be good as no critical events occurred and
all participants were able to complete all the tests, though some of them received complementary
TUGdt instructions, e.g., if they stopped walking. On the other hand, the systematic analysis of
the TUGdt video recordings revealed that deviant mobility or (more seldom) verbal performances
were common in the entire group (21 out of 43), particularly among those with DD (15 out of 25).
Examples of TUGdt video recordings (filtered to preserve personal integrity) includes one person
with MCI (Supplementary Video S1: Woman with Mild Cognitive Impairment) and one with an
established dementia diagnosis (Supplementary Video S2: Woman with Dementia Diagnosis), the latter
of whom became quiet, stopped and repeatedly stood still when she conducted her TUGdt test, despite
being instructed to prioritize the mobility task (see Supplementary Video S2: Woman with Dementia
Diagnosis). Video analysis results (summarised in Table 2A) provided a basis for the refinement of
the verification protocol for the purpose of future video analyses (Table 2B) as well as improvements
of the instruction protocol for the TUG tests. The purpose of the latter was to make the instructions
more precise, e.g., by including in which situations and how to use cueing, feedback, and repetition
(Appendix A). It was estimated that the entire data collection procedure, in terms of tests, did not take
more than 30 min/participant. Taking the participants’ status with possible fatigability into account,
there was still space for completions of the UDDGait protocol with more assessments as suggested by
the expert group (see interpretations and development of the UDDGait protocol below).
3.2. Explorations of the TUGdt Outcome Measures
The assessment of the reliability of the digitalised SL showed a mean intra-assay CV of 0.69%
(range 1.4%–2.3%) and a range of SL of 0.26 to 0.73 m, which was judged as satisfying.
The statistical analyses of the sub-sample’s (n = 22) results showed that the DD group had
significantly lower MMSE scores (median 20.0 vs. 27.5, p = 0.05) than NoDD. Comparisons between
these groups showed no significant differences in any of the time scores of TUG, TUGdt, TUGdt cost,
or named animals per ten seconds (Table 3). Significant (p < 0.005) differences were only shown for the
number of animals named after the TUGdt turning point and SL difference after/before the TUGdt
turning point. After the TUGdt turning point, the NoDD group was able to name significantly more
animals than the participants of the DD group (Md 3.5 vs. 1.0, p < 0.05). However, no group difference
was found in the number of named animals before turning or for the entire TUGdt test (Table 3).
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Table 3. Results of Timed Up-and-GO (TUG) and TUG dual-task (TUGdt) test measurements in patients
with dementia disorder diagnosis and no established dementia diagnosis. Significant p-values in
bold font.
Variable
With Dementia (N = 10) No Dementia (N = 12) Adjusted
p-Value *Min Md Max Min Md Max
TUG time (s) 10.4 18.1 30.2 7.5 14.4 19.4 0.342
TUGdt time (s) 13.9 28.7 55.0 10.2 17.6 41.9 0.149
TUGdt cost (%) 15.3 37.8 217.6 1.0 27.3 115.9 0.972
TUGdt animals before turning (n) 1 3 7 0 4 6 0.418
TUGdt animals after turning (n) 0 1 3 0 3.5 5 0.045
TUGdt animals difference after/before turning (n) −5 −2 0 −4 −1.5 5 0.418
TUGdt animals per 10 (s) 0.76 1.8 4.3 1.3 4.9 8.2 0.245
TUG SL before turning (m) 0.251 0.415 0.625 0.431 0.588 0.746 0.149
TUG SL after turning (m) 0.254 0.386 0.637 0.351 0.534 0.704 0.342
TUG SL difference after/before turning (m) −0.175 −0.017 0.012 −0.222 −0.020 0.084 0.597
TUGdt SL before turning (m) 0.215 0.385 0.593 0.353 0.568 0.718 0.062
TUGdt SL after turning (m) 0.236 0.373 0.605 0.320 0.502 0.671 0.379
TUGdt SL difference after/before turning (m) −0.047 −0.020 0.027 −0.118 −0.049 −0.023 0.032
* Comparison between groups using Wilcoxon’s two-sample test and adjusted for age, gender and height with
Willett’s residual method; Min = minimum, Md = Median, Max = maximum; TUG = Timed Up-and-Go, TUGdt = TUG
dual-task, SL = step length.
In this study sample, SL was negatively correlated with age, which was shown for both TUG and
TUGdt tests (r = −0.63 to −0.68, p < 0.003). The average SL for TUG (Md = 0.402 m for the DD group
and 0.555 m for the NoDD group) appeared longer than the average SL for TUGdt (Md = 0.382 m for
the DD group and 0.538 m for the NoDD group) in both groups (see Figure 2). After adjustments for
age, gender, and height, there was no difference shown in average SL between the groups in the total
TUG or TUGdt performances. However, it was observed that the majority of participants altered their
TUG test performances after turning by taking shorter steps in both TUG and TUGdt (Figure 2 and
Table 3). In the whole study sample, SL was significantly shorter after turning than SL before turning
in TUGdt (p = 0.006). The same tendency was also observed in the TUG test (p = 0.055). Furthermore,
the number of animals named in TUGdt was significantly lower after turning (p = 0.01). Significant
group differences were shown concerning SL change before vs. after turning in TUGdt (p = 0.031),
but not in TUG (Figure 2). Notably, all individuals with NoDD shortened their SL after turning in
TUGdt, whereas results varied in the DD group (Table 3). In TUG single-task SL, outcome variation
between individuals was high in both groups (Figure 2).
3.3. Interpretations of Pilot Results and Development of the UDDGait Protocol
The analyses of the video-recordings, as well as recurrent consensus discussions with the
interdisciplinary expert group, gave opportunities for feedback and ideas of improvements of the study
protocol, its procedures, and choice of outcome variables. Based on the overall results, the following
improvements were made to enable a more comprehensive description of participants the protocol
was completed with three standard clinical cognitive assessment results, i.e., the Trail Making Test A
and B, the Verbal Fluency Test [37] (collected from the medical records) and a depression screening
using a short version of the Geriatric Depression Scale [44], as well as a balance test [45]. These were
incorporated into the protocol as a complement to assessments of hand grip strength of the dominant
hand using a dynamometer, the General Motor Function Assessment Scale [36], the Mini Mental State
Examination (MMSE) [8], and the Clock Test [37]. Also, another TUGdt test—TUG combined with the
task of reciting the months of the year in reverse order—was added, which was thought to be a more
challenging task than naming animals. It places demands on declarative memory and working memory
and has been shown to possess a significant diagnostic classificatory power regarding individuals
with mild AD, MCI, and SCI [46]. Besides our TUGdt animals and TUGdt months, different types of
cognitively challenging tasks (e.g., naming items, calculations, reciting the alphabet) have previously
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been paired with a mobility task to form dual-task tests. However, there is still no consensus concerning
what tasks to combine to accomplish an optimal dual-task test and these tasks should not be viewed as
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Additionally, refinement of the checklist for a more detailed data collection protocol was performed,
including instructions of TUG and two types of TUGdt (Appendix A). A new verification protocol was
developed for the examination of TUGdt-video recordings to determine which performances could
be judged as normal vs. deviant (Table 2B). Establishment of blinded (in relation to diagnosis) data
collection and processing of all clinical tests will be applied as a rule in the UDDGait protocol.
In an effort to catch most of the potential of the TUGdt outcome, we explored some novel and rarely
used measures including verbal performance (number f animals recit d) and a gait par meter (SL)
before and after th TUGdt turning point, as well as numb r of animals per ten seconds, whi h were
calculated alongside the more established time scores. It is to be noted that although dual-task testing
consists of a combination of two tasks—most commonly a verbal and a mobility task—the verbal
performance has rarely been reported, though words per ten seconds during usual pace gait have
been recorded in one previous study [22]. Thus, the full potential of the test results may not have
been completely considered in research. Given the small sample size, which was consistent with our
aim directed towards protocol development, all the explored TUGdt outcome measures should be of
interest for further examination in more extensive UDDGait investigations.
3.3.1. The Refined Protocol for the Large-Scale UDDGait Study
The UDDGait is designed as a prospective cohort study with experimental elements, focusing
on the analysis of if and how TUGdt outcomes can predict cognitive decline and dementia disorders.
It includes investigations of reliability and normative reference values of TUGdt outcomes (Figure 3).
Patients attending a specialist clinic for memory assessments at the Uppsala University Hospital
or the Falun Regional Hospital were recruited before they are diagnosed and then followed over a
four-year period. Inclusion criteria for this population: Patients who undergo memory testing at
specialist clinics. Exclusion criteria: difficulties in carrying out verbal instructions given in Swedish
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(due to, e.g., restrictions for vision/hearing or needing an interpreter), health problems that significantly
limit the ability to walk, indoor use of a walker, and the inability to get up from a sitting position.
For the identification of cut-off values of TUGdt results for individuals with different levels of cognitive
functioning (SCI, MCI, and dementia diagnosis) and for the longitudinal prospective sub-studies
(Studies I, V and VI; Figure 3), 305 patients were recruited in accordance with the statistical power
analysis presented below. Follow up assessments were performed two and four years after the baseline
with patients who had not developed a dementia disorder until this time and the medical records from
all these individuals will be reviewed mainly to identify any new cognition related diagnoses. Due to
the ethical approval, we have an additional opportunity to follow these patients through their medical
records for another four years. For the reliability test among patients visiting a specialist clinic for
memory assessment (Study II), 50 patients will be included to enable a sub-group analysis (Figure 3).
For Study III, research participants without cognitive impairment will be recruited through
advertising and community-based organisations for retirees. We are planning to include
15–20 individuals from each gender group (female/male) in the age groups 50–59, 60–69, 70–79 and
80 and older, i.e., a total of 120–160 research participants. Inclusion criteria: no experienced memory
problems or self-reported severe mobility limitations. Exclusion criteria are the same as above, with the
addition of MMSE <27. For the reliability test in this population (Study IV), 30 participants will be
included (Figure 3).
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The data collection for all participants follows the same procedure (see Section 3.3), and will be
repeated for the reliability testing and longitudinal investigations. The TUGdt outcome measures
described above (Section 3.2) will be further investigated.
3.3.2. Statistical Power Calculation for the UDDGait-Protocol
Our starting point was that TUGdt cost (the most established dual-task outcome) can demonstrate
significant differences between those who will develop and those who will not develop a dementia
disorder in the included population that undergoes memory assessments at specialist clinics.
Our hypothesis is that TUGdt cost has a predictive capacity with a c-statistic of ≥0.8. As such,
198 patients are required in order to attain a 90% probability (power) that the lower confidence limit is
>0.7, presuming that 1/3 of the patients will develop dementia within three years (based on data from
previous studies). Our presumption that c >0.7 is clinically relevant: i.e., that approximately 70% of
the predictions will prove to be correct. So as to compensate for an expected proportion of 35% who
will demonstrate a dementia diagnosis at the baseline measurement stage, 305 patients are required
for inclusion. For each of the reliability studies, we aim to evaluate 30 and 50 participants/patients,
respectively. The larger population has the purpose of enabling a subgroup analysis for patients that
receive the MCI diagnosis. We assume that ICC for TUGdt cost is >0.85, and this implies that the
length of a 95% confidence interval for ICC is <0.10.
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4. Discussion
To the best of our knowledge, this study is the first to examine the feasibility of dual-task testing in
a non-laboratory clinical setting among individuals undergoing memory assessments, using systematic
analyses of video-recorded tests. This implies that we report on the preparatory processes, including
piloting and feasibility evaluation, for the development of a large-scale study, which corresponds to
inquiries for this kind of publication. It has been claimed that it is important to meet the need for
more such publication [47], also concerning non-randomised studies since reporting can be beneficial
for researchers in learning across disciplines, reusing techniques and avoiding repetition of similar
pitfalls. [34] However, uncertainty still remains in how to report such work [34]. The only previous
dual-task feasibility study found was laboratory-based and included participants with a dementia
diagnosis [48]. It included tests conducted on an instrumented walkway with usual walking combined
with various verbal tasks (including naming animals). Both walking and talking were, in contrast
to our TUGdt, supposed to be performed as fast as possible without prioritizing one of them [48].
Such instructions may be experienced as stressful for a population undergoing memory assessment
and the response may not be indicative of current functional status [49]. Nevertheless, it was indicated
that such dual-task tests could be suitable as a diagnostic or descriptive tool for cognitive decline [48].
The current feasibility analysis with a video-based methodology enabled systematic and repeated
observations of both mobility and verbal performances for the discovery of uncertainties concerning
the interplay between test administration and participants’ responses to the assessment instructions
and validation of the data collection. This kind of information is seldom presented in research [24].
The only dual-task study found in which the quality of participants’ performances was analysed;
performances analyses categorised performances as normal, moderate deviation, or severe deviation,
which was apparently based on observations at the same time as the testing occurred [50]. In that study,
it was found that 98% of healthy controls, 62% of those with MCI, and 35% of those with Alzheimer’s
disease were categorised as having normal performance, which emphasizes the importance of paying
attention to and managing these phenomena to improve the test validity. Moreover, categorisation
based on cautious analyses of TUGdt performances might be used as an outcome measure in its own
right, since deviant performance can be associated with the progression from MCI to dementia [29].
It has been suggested that the qualitative evaluation of dual-tasking may outperform quantitative
measures when it comes to differentiating between progressive and stable MCI [50], but this hypothesis
still needs further investigation. It is preferable for such analyses to be based on video-recorded tests
to ensure a high degree of reliability.
As shown by our video analyses, deviant performances occurred in all the TUG sub-sequences:
initiation and rising up, walking forward, crossing the line and turning back, and walking back and
sitting down (Table 2A). One participant with DD recurrently stopped both talking and walking during
the TUGdt test (see Supplementary Video S2: Woman with Dementia Diagnosis), which might be a
sign of the test not being the best suited for individuals with moderate to severe dementia disorders.
However, it appears to be executable for individuals with less severe cognitive impairments and hence
suitable to work as a screening tool for the prediction of dementia incidences. The identification of
deviant performances provided a basis for the development of the UDDGait data collection protocol
concerning the improved specification of test instructions, including the standardisation of reasons for
and how to use cueing, as well as when feedback and test repetition are to be used. These specifications
should decrease the risk for both longer durations of stop-walking-while-talking [51] occurrences and
unstructured encouragement, and thereby improve the assessment validity [52]. This is also in line
with previous research arguing that it is critically important to advance the use of assessments of the
cognitive motor interference by dual-tasking and that the use of a more standardised approach that
allows comparisons is urgent in both research and clinical settings [41]. Such standardisation with the
presentation of specified instructions may be of particular importance when TUG is used for dual-task
testing, as it is a more complex mobility task than using ordinary gait alone.
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In line with guidelines concerning pilot and feasibility study aims [47], our exploration of TUGdt
outcome measures was not designed or powered to address hypothesis testing. This is an objective for a
large-scale UDDGait study. In contrast, the current exploration was aimed at evaluating the procedures
for data collection, preparation and analyses and at indicating selection of the most appropriate
outcome measure (s). It was therefore not surprising that we did not find any differences between
the DD group and the NoDD group in any of the temporal outcomes, including dual-task cost or
in the number of animals per ten seconds. Despite this, thought-provoking results from the current
study revealed that the NoDD group named significantly more animals than participants in the DD
group after turning: 3.5 vs. 1.0. Additionally, a significant difference was found concerning a change
in SL after the turning point in TUGdt (but not in TUG), explained by the fact that all individuals
in the NoDD group shortened their SL after turning, whereas these results varied in the DD group.
These results correspond to some of the results from a recent study, in which an instrumented walkway
was used for an extended (ten meters) version of the TUG test [53]. In that study, four gait parameters
other than SL, namely, velocity, stride velocity, and the proportion of the double support phase with
respect to gait cycle duration, showed a statistically significant difference between gait for walking
away and walking back in persons with Parkinson’s disease, but not in healthy controls. Hence,
it appears that our comparisons of SL generated some interesting results. Data extraction of SL from
video-data was, however, time-consuming.
All of the above outcome measures are considered to be feasible and potentially appropriate
for future investigations in a larger sample in the large-scale study. The time-related outcomes are
interesting since they are the most established outcomes from dual-task testing and may, hence, provide
opportunities for comparisons with other research results. Additionally, an UDDGait sub-study of
90 participants (age range 49–84 years) undergoing memory assessment showed that the number of
correct animals named, as well as the number of correct animals named per ten seconds during TUGdt,
correlated with biomarkers for AD (t-tau and p-tau) [54] and that preliminary UDDGait baseline
results [55] have also indicated that TUGdt outcomes “words per time unit”, i.e., “animals per 10 s”
and “months per 10 s” can discriminate between groups of individuals with early-stage dementia
diagnoses, MCI, SCI, and healthy controls.
The SL and other step parameters are interesting but a large sample would presumably require
a more semi-automated system with less manual elements, which would open the way for the
examination of more spatiotemporal gait parameters. Such a development has the potential of being
fruitful, as research results have indicated that specific gait characteristics derived from dual-task tests
(and usual pace walking) in a preclinical stage and in MCI, are associated with the risk of developing
specific dementia types [27]. We therefore aim for the development of a system that can extract gait
parameters from video recordings, based on deep-learning methods [56] as a UDDGait side-project.
5. Study Limitations and Strengths
This study has a number of limitations that should be taken into consideration when interpreting
the results. The pilot sample size was quite small, which implies a risk of missing possibilities of
discovering uncertainties concerning the interplay between TUGdt administration and participants’
performances as well as true group differences, which in turn limits the possibility for generalizing the
results. Moreover, the grouping of participants can be questioned since three individuals of the NoDD
group, at the time of the data collection, were involved in an ongoing process of memory assessment
with unknown final results. On the other hand, the group differences of MMSE scores (Table 1) indicate
that the NoDD and DD groups differ in degree of cognitive impairment. Strengths of the methodology
used include the use of video-recordings that enable cautious and repeated observations and analyses
of the TUG and TUGdt performances and the reliability test of the processing for achieving SL data
from the video recording, which showed satisfying results.
There are several advantages to using video recordings: the equipment is inexpensive, assessable
and does not require a large amount of space, which makes it useful in a clinical environment. Moreover,
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these recordings allow for the simultaneous data collection of mobility and verbal performances and,
if desired, it can also be used for collecting data on timing. However, the extraction of gait parameters in
an effective way suitable for clinical practices will require the development of a system that provides this
in a reliable, fast and semi-automatic manner. Since the long term goal of this pilot study is to provide
results that can guide the design of more extensive studies including later clinical implementation
studies, the clinically-based approach with the use of transportable and inexpensive equipment and
with a combination of well-established and easily performed test procedures may also be viewed as
a strength.
6. Conclusions
To the best of our knowledge, this is the first study that examines the feasibility of TUGdt testing
through the use of systematic analyses of video-recorded tests in a clinical setting. Additionally, our
exploration of TUGdt outcomes involved some novel measures, such as the number of words (animals)
recited per ten seconds and numbers of words and SL before and after the turning point in TUGdt.
Despite some deviant TUGdt test performances identified through the videos, the test procedures are
judged to possess the potential for good feasibility after protocol refinements were made. The TUGdt
outcomes showed some promising results by indicating that changes in SL and possibly also the
number of words correctly recited during TUGdt testing could be relevant parameters to investigate
as a marker for dementia. Follow-up studies with larger samples focused on the investigation of
these parameters in populations with sub-groups of individuals with different degrees of cognitive
functioning, including healthy controls, are being carried out to provide a basis for possible clinical
implementation of the TUGdt test.
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Appendix A
Appendix A.1. Data Collection of Timed Up-and-Go (TUG) and Two Types of TUG Dual Task (TUGdt):
TUGdt Animals and TUGdt Months
Appendix A.1.1. TUG and TUGdt Tests
TUG and TUGdt tests are performed according to a standardized set up and procedures including
video recordings with moving image and sound recordings. The video cameras are mounted on tripods,
one with a frontal view and one with a lateral view, and synchronised for data collection.
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Appendix A.1.2. Two TUGdt Tests
TUG combined with “name different animals” and “recite the months of the year in reverse order”,
respectively. Both tasks are to be completed at the participant’s own speed and with the instruction
to prioritise the walking part—i.e., if the participant is unable to say words, he/she should continue
walking and continue to complete the movement sequence.
Appendix A.1.3. TUG Test
Preparation: Place a chair (46 cm in height) with armrests three metres from a line made by a
clearly visible strip of tape on the floor, parallel to the front legs. The distance is measured from the
front legs of the chair.
Starting position: The participant sits on the chair with his/her arms on the armrests and his/her
back against the backrest.
Execution: The test begins with the assessor describing and showing how the test is performed
(see point 2 of instructions below).
The participant should perform the following sequence of movements at his/her own comfortable
pace: From sitting in a chair with armrests, get up, walk three metres, pass over the floor marking
(a clearly visible strip of tape on the floor), turn around on the other side of the line, walk back and sit
down in the chair.
1. Pre-trial: The participant performs the TUG test once without timing: “You can try now”.
If necessary, supplementary instructions are given while the participant is performing the
trial test.
2. TUG single-task (timed): The following instructions are given to the participant immediately
before the test is performed: “When I say start, you should rise up, walk towards the line, cross
the line, turn back, walk back and sit down in the chair. You should walk normally, as you usually
do, at your own pace. Are you ready?” After an affirmative answer, the assessor says: “You can
start now”. Timing starts when the participant’s back leaves the chair back and ends when the
participant’s posterior touches the seat. Oral clues are provided if necessary and noted in the
minutes (see below: IMPORTANT).
3. TUG dual-task (Animals): The following instructions are given to the participant “You should
do what you just did, but at the same time as you walk, please name different animals aloud.
You can choose any animals you want. If you get stuck and cannot think of any animals, just keep
walking like you just did now”.
Answer any questions.
Ask the question: “Are you ready?”. After an affirmative answer, the assessor says: “You can
start now”. The assessor times the performance. (The number of different animals is extracted
from the video recordings).
4. TUG dual-task (Months): The following instructions are given to the participant “You should
do what you just did, but at the same time as you walk, please recite the months of the year in
reverse order. So you should start with the last month. If you get stuck and do not know what
month to say, just keep walking like you just did now. You don’t have to recite all of the months”.
Answer any questions.
Ask the question: “Are you ready?”. After an affirmative answer, the assessor says: “You can start
now”. The assessor times the performance. (The number of months in correct order is extracted
from the video recordings).
Appendix A.2. Important Considerations
The starting point is when the participant knows how the TUG-single task test is to be performed.
Repeat the instructions if needed and clarify them if necessary. Supplement with a new
demonstration if needed. Note extra instructions in the protocol.
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If the participant asks what to do immediately after rising up from the chair when the test is
initiated, cancel. Provide renewed instructions and a demonstration and restart. Restart is allowed
only once.
The following oral clues can be given to participants during the ongoing test and should be noted
in the protocol. Gestures, e.g. to invite the participant to sit on the chair, are noted as “clue”.
1. Briefly answer questions about the execution.
2. Give the instruction “turn”, if the person does not turn when passing the floor marking but walks
straight ahead towards the camera in front.
3. Give the instruction “sit down” if the person on the way back stops next to the chair and
remains standing.
4. If the participant slows down or makes short stops (≤10 s) at other times during the test,
no encouraging instructions are given.
5. In cases where the person has obviously forgotten what to do, or expresses that s/he cannot
perform the test, encouragement to continue walking is given.
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